PUBLISHER: The Business Research Company | PRODUCT CODE: 1829834
PUBLISHER: The Business Research Company | PRODUCT CODE: 1829834
Viral diagnostic test kits are instruments used in medicine to detect viral infections in clinical samples from patients. These kits typically contain reagents, antibodies, or other substances that interact with specific viral antigens or genetic material, generating a measurable signal. They can detect viral particles, antigens, or genetic material (such as RNA or DNA) in samples such as blood, saliva, nasal swabs, or other bodily fluids.
The main types of viral diagnostic test kits include traditional tests and rapid tests. Traditional viral diagnostic tests are established laboratory-based methods that involve culturing the virus, detecting viral antigens, or measuring antibody responses. Examples of these tests include direct fluorescent antibody (DFA) tests, immunochromatographic assays, reverse transcriptase polymerase chain reaction (rt-PCR) based tests, agglutination assays, solid phase assays, flow through assays, and others. These tests are used by various end-users including research laboratories, clinics, hospitals, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The viral diagnostic test kits market research report is one of a series of new reports from The Business Research Company that provides viral diagnostic test kits market statistics, including viral diagnostic test kits industry global market size, regional shares, competitors with viral diagnostic test kits market share, detailed viral diagnostic test kits market segments, market trends, and opportunities, and any further data you may need to thrive in the viral diagnostic test kits industry. This viral diagnostic test kits research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The viral diagnostic test kits market size has grown strongly in recent years. It will grow from $16.26 billion in 2024 to $17.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing healthcare expenditure, increasing global travel, a rise in chronic viral infections, a rise in demand for home testing kits, and growth in personalized medicine.
The viral diagnostic test kits market size is expected to see strong growth in the next few years. It will grow to $23.4 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing Ebola virus infections, increasing hemorrhagic fever, rising prevalence of viral infections, increasing prevalence of respiratory syncytial virus, and increasing prevalence of hepatitis. Major trends in the forecast period include technological advancements, point-of-care testing, AI and data analytics, integration with digital health records, and next-generation sequencing.
The forecast of 7.6% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for viral antigen reagents and lateral flow assay components, sourced from key regions such as China and South Korea, could lead to testing shortages during outbreaks and increased diagnostic expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of viral infections is anticipated to drive the growth of the viral diagnostic test kits market in the coming years. Viral infections are caused by microscopic viruses that invade host cells, replicate within them, and can result in a wide range of symptoms, varying from mild to severe, affecting different parts of the body. This rise in infections is attributed to factors such as global travel, urbanization, climate change influencing vector-borne diseases, and the emergence of new viral strains capable of causing outbreaks or expanding into new regions. Viral diagnostic test kits play a crucial role in identifying and confirming specific viral infections by detecting viral nucleic acids (RNA or DNA), antigens, or antibodies in biological samples such as blood, saliva, or nasal swabs. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2022, there were 2,126 new cases of acute hepatitis B reported alongside 16,729 newly reported cases of chronic hepatitis B in the United States. Additionally, 14 jurisdictions in the US reported rates of acute hepatitis B higher than the national average, highlighting the need for effective diagnostic tools. Therefore, the increasing prevalence of viral infections is a key driver behind the growth of the viral diagnostic test kits market.
Leading companies in the viral diagnostic test kits market are focusing on developing innovative products, such as virus detection kits, to maintain their competitive edge. A virus detection kit is a diagnostic tool designed to detect specific viruses in biological samples, offering quick and accurate results to support effective disease monitoring and management. For example, in August 2024, BlueStain Global Ltd, a UK-based company, introduced the MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic test that identifies the mpox virus with high speed and accuracy, providing results in just 15 to 30 minutes. This innovative kit aims to improve public health responses by enabling early detection and containment of mpox outbreaks, especially in resource-limited environments.
In June 2023, Avacta Life Sciences, a UK-based company in the life sciences sector, completed the acquisition of Coris Bioconcept for £7.4 million ($9.35 million). This strategic move by Avacta is aimed at bolstering its rapid diagnostic test portfolio, thereby strengthening its capabilities in healthcare diagnostics and expanding its market presence, particularly in the fields of infectious disease management and point-of-care testing. Coris Bioconcept, based in Belgium, specializes in the development and manufacturing of rapid diagnostic test kits, primarily focusing on lateral flow tests designed to detect viral and bacterial pathogens.
Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc, Biodesix Inc.
North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the viral diagnostic test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The viral diagnostic test kits market consists of sales of viral culture kits, molecular diagnostic kits, antibody detection kits, antigen detection kits, and multiplex PCR kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viral Diagnostic Test Kits Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on viral diagnostic test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for viral diagnostic test kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral diagnostic test kits market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.